Vimarsana
Biggest News Aggregation in the World

Novel Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novel Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novel Pharma Today - Breaking & Trending Today

GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance - Vimarsana News

GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance

Published: May 21, 2024

GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A....

Source: lelezard.com
Related Topics:
United StatesSouth KoreaSoult UkpyolsiHeparann SulfataseSohee KimPharma SanfilippoRachel KimYelin JunGc Biopharma CorpGreen Cross CorporationNovel Pharma IncNovel PharmaSanfilippo Syndrome TypeOrphan Drug DesignationRare Pediatric Disease DesignationSyndrome Type
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) - Vimarsana News

European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

Published: January 23, 2024

/PRNewswire/ -- GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its...

Source: prnewswire.com
Related Topics:
South KoreaYelin JunRachel KimSohee KimEuropean Medicines AgencyGc Biopharma CorpPrnewswire Gc Biopharma CorpGreen Cross CorporationOrphan Drug DesignationEnzyme Replacement TherapySanfilippo SyndromeRare Pediatric DiseaseNovel PharmaGc BiopharmaHealth Care Amp HospitalsMedical PharmaceuticalsFda ApprovalInternational Medical Approval